US Center for Devices and Radiological Health set to gain from FDA push for more efficient use of data
This article was originally published in Clinica
Executive Summary
The US FDA has decided to establish an additional layer of managerial scrutiny and push for greater use of outside databases in order to close the gaps in its leaky post-market surveillance programme for devices.